Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol Nebulizer vs MDI with Spacer in Acute Asthma
NCT03816267Phase 3Completed
- Sponsor
- Suez Canal University
- Start
- May 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of salbutamol in asthma (2 arms), sponsored by Suez Canal University. Primary endpoint: Clinical improvement (Respiratory Score < 4) at 1 hour. Started May 2018; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03816267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03816267.